EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis

Hong Xin iD, Jonothan A Rosario-Colon, Karen Eberle

mSphere · 2023

DOI: 10.1128/msphere.00584-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2023. Verfasst von Hong Xin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Louisiana State University Health Sciences Center, Department of Microbiology, Immunology, and Parasitology, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Candida albicans, Candidiasis, Invasive. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | National Institutes of Health (NIH), U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since current antifungal treatments are ineffective in the immunocompromised population and no vaccine is available for humans, hope remains that antibody preparations selected for specific fungal antigens may make it possible to reduce the incidence and mortality of invasive candidiasis. Intravenous immunoglobulin (IVIG) has long been approved as a standard treatment for patients with immunodeficiency disorders who are also susceptible to fungal infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansCandidiasis, InvasiveImmunoglobulins, IntravenousAntifungal AgentsMice, Inbred C57BLHumansCandidaCandidiasisAnimalsCandida aurisAmphotericin BMicePolysaccharides

Stichwörter der Autor:innen

Candida albicansCandida aurisIVIGadjunctive immunotherapyantibody functiondisseminated candidiasismultidrug resistance

Substanzen

Immunoglobulins, IntravenousAntifungal AgentsAmphotericin BPolysaccharides

Autor:innen und Institutionen

  • Louisiana State University Health Sciences Center, Department of Microbiology, Immunology, and Parasitology, New Orleans, Louisiana, USA.

ORCID-Profile: Hong Xin

Förderung

  • HHS | National Institutes of Health (NIH)
  • U.S. Department of Defense

Zitieren

APA

Xin, H., Rosario-Colon, J. A., & Eberle, K. (2023). Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis. mSphere. https://doi.org/10.1128/msphere.00584-22

Vancouver

Xin H, Rosario-Colon JA, Eberle K. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis. mSphere. 2023. doi:10.1128/msphere.00584-22

BibTeX
@article{Xin2023,
  author = {Xin, Hong and Rosario-Colon, Jonothan A and Eberle, Karen},
  title = {Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis},
  journal = {mSphere},
  year = {2023},
  doi = {10.1128/msphere.00584-22}
}
Kostenlos starten →